Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, ...

Today, our scientists and doctors are transforming cancer care through precision immuno-oncology — tailoring immunotherapy treatments to the unique biology of each patient's cancer. At MSK, ...

False claims that COVID-19 mRNA vaccines cause cancer could, ironically, lead to worse cancer outcomes by undermining a promising tool to prevent and treat it.

Kyntra Bio, Inc. (NASDAQ:KYNB) Q4 2025 Earnings Call Transcript March 16, 2026 Kyntra Bio, Inc. beats earnings expectations. Reported EPS is $-3.61, expectations were $-3.885. Operator: Thank you for ...

A 1951 CIA report on parasites and tumors spread online in March 2026 — but it was declassified years ago and does not reveal a cancer cure.

Phase 2 monotherapy trial of FG-3246, a potential first-in-class antibody drug conjugate (ADC) targeting CD46, in metastatic castration-resistant prostate cancer (mCRPC) is actively enrolling and rema ...

Recent advances in drug discovery research have led to the development of numerous drug candidate compounds with high therapeutic efficacy.

Much of the new FDA food guidance aligns with existing advice, but some areas may introduce confusion to advising patients on diet and cancer prevention and survival.

A handful of small, early-stage clinical trials are investigating whether CAR-T therapy can improve symptoms in multiple ...

A protein tied to ALS and dementia may have a much bigger role in disease than scientists realized. Researchers found that ...

Marisa Peters, 44, a mother of three and former Broadway vocalist, first noticed bleeding when going to the bathroom after ...

Ongoing activities, including new engagement to relist on Nasdaq, new board member, continued advancement of Phase 1 trial into MDS patients, ...